Patent Board’s Rejection Of Obviousness Challenge Affirmed By Federal Circuit
WASHINGTON, D.C. — Findings by the Patent Trial and Appeal Board that 23 claims of a patented composition for tigecycline and an acid or buffer are not obvious were not erroneous,...To view the full article, register now.
Already a subscriber? Click here to view full article